Lighthouse Medical Center Expands Regenerative Medicine Clinic Operations

Lighthouse Medical Center announced the expansion of its regenerative medicine clinic as part of a broader initiative to ...
PharmiWeb

nChroma Bio Receives Authorization of Clinical Trial Application to Initiate First-in-Human Study for Epigenetic Silencer CRMA-1001 for the Treatment of Chronic Hepatitis B

First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...